Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
Author Information
Author(s): Garrido-Urbani Sarah, Jemelin Stephane, Deffert Christine, Carnesecchi Stéphanie, Basset Olivier, Szyndralewiez Cédric, Heitz Freddy, Page Patrick, Montet Xavier, Michalik Liliane, Arbiser Jack, Rüegg Curzio, Krause Karl Heinz, Imhof Beat
Primary Institution: Department of Pathology and Immunology, Centre Médical Universitaire, University of Geneva, Geneva, Switzerland
Hypothesis
NOX1 is a critical mediator of angiogenesis and an attractive target for anti-angiogenic therapies.
Conclusion
Vascular NOX1 is essential for angiogenesis and tumor growth, making it a potential target for cancer therapies.
Supporting Evidence
- NOX1-deficient mice showed impaired angiogenesis compared to wild type mice.
- NOX1 expression and activity increased in endothelial cells upon angiogenic stimulation.
- Silencing NOX1 reduced endothelial cell migration and tube formation.
- Administration of a NOX-specific inhibitor reduced angiogenesis and tumor growth in vivo.
Takeaway
This study found that a protein called NOX1 helps blood vessels grow in tumors, and blocking it could help treat cancer.
Methodology
The study used in vivo Matrigel angiogenesis assays and various endothelial cell models to analyze the role of NOX1 in angiogenesis.
Limitations
The study primarily focused on the role of NOX1 and did not explore the potential compensatory mechanisms involving other NOX isoforms in detail.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website